National Health Investors (NHI) Net Income towards Common Stockholders (2009 - 2026)

National Health Investors has reported Net Income towards Common Stockholders for 15 years, with the latest figure at $40.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 17.33% year-over-year to $40.0 million; the trailing twelve-month figure through Mar 2026 stood at $147.9 million (up 4.84% YoY), and the FY2025 full-year result was $142.0 million, up 2.98% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $40.0 million, up from $38.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $43.2 million in Q4 2024, with the low at $1.9 million in Q4 2022.
• Historically, Net Income towards Common Stockholders has averaged $32.1 million across 5 years, with a median of $34.3 million in 2022.
• The largest YoY upside for Net Income towards Common Stockholders was 1619.11% in 2023 against a maximum downside of 14.92% in 2023.
• National Health Investors' Net Income towards Common Stockholders stood at $1.9 million in 2022, then soared by 1619.11% to $32.0 million in 2023, then surged by 34.93% to $43.2 million in 2024, then slipped by 11.8% to $38.1 million in 2025, then climbed by 5.01% to $40.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $40.0 million (Q1 2026), $38.1 million (Q4 2025), and $32.8 million (Q3 2025), per Business Quant data.